It’s half a century since the first known HIV-related death and two patients appear to have been cured of the virus. What does this mean for the 37 million still living with it? Read the full article in The Guardian.
A second person has experienced sustained remission from HIV-1 after ceasing treatment, reports a paper led by researchers at UCL and Imperial College London. The case report, published in Nature and carried out with partners at the University of Cambridge and the University of Oxford, comes ten years after the first such case, known as the ...
Oxford University, through its innovation arm Oxford University Innovation (OUI), has entered into an option agreement for a universal influenza vaccine with US-based startup Blue Water Vaccines (BWV), which is raising $15m to support development of the flu shot. Further information is available here.
The main aim of Medawar Day is to have one day where the different labs can share their work and we can all get some sense of what is going on – it is not a huge building but it is still easy to miss out. We hope the programme will spark some conversations and some joint projects so we can all get the best out of the opportunities that come from ...
The CHERUB HIV garden is a landmark project for, and about, people living with HIV. It was launched at the RHS Chelsea Flower Show 2018 and then moved to a permanent site in Brent. Facilitated by professional garden designers, HIV clinicians, researchers and community link workers, over 12 months young people living with HIV developed a garden ...
A new clinical trial will test whether it is possible to destroy hidden reservoirs of HIV virus that are a key obstacle to curing the disease.
The RIVER trial is one of the first clinical trials to test a new idea of how to cure HIV. As well as standard HIV treatment, it includes different medicines that wake-up a 'reservoir' of infected cells that have sleeping virus inside them and kills them using the body’s own immune system.
HIV is evolving to become less deadly and less infectious, according to a major scientific study. The team at the University of Oxford, lead by Prof Philip Goulder, shows the virus is being "watered down" as it adapts to our immune systems. The study said it was taking longer for HIV infection to cause Aids and that the changes in the virus may help efforts to contain the pandemic. Some virologists suggest the virus may eventually become "almost harmless" as it continues to evolve.
Hepatitis is a viral infection that causes acute and chronic disease, and sometimes death. World hepatitis day takes place each year on 28th July and the aim of this year’s World Health Organization’s campaign is to raise awareness of viral hepatitis. NDM spoke to Paul Klenerman, Professor of Immunology, about his research on Hepatitis C and the advances that are being made in treatment approaches.
The Peter Medawar Building for Pathogen Research website has been re-vamped and re-launched! We hope that you will find the new site accessible and helpfull. We welcome any suggestions that you might have to improve the site, or changes that you would like to see. In the first instance please contact Suki Kenth.